期刊文献+

胰腺癌切除术后预后相关因素的临床分析 被引量:2

Clinical analysis of prognostic factors in the postoperative pancreatic cancer
下载PDF
导出
摘要 目的通过回顾性分析78例胰腺癌手术切除患者的生存情况,探讨胰腺癌切除术后影响患者生存的临床及病理因素。方法将2005-2008年间哈尔滨医科大学附属第三医院收治的78例胰腺癌手术切除病例的临床资料进行回顾性分析,用Kaplan—Meier法对可能影响预后的指标:年龄、性别、血糖、血型、疼痛症状、术前CA19—9、肿瘤部位、淋巴结转移、临床分期及辅助治疗进行单因素分析,并用Cox比例风险模型对单因素分析结果中的阳性指标进行多因素分析。结果单因素分析显示术前CA19—9、术后病理淋巴结转移情况、辅助治疗、临床分期和伴有疼痛症状是影响术后胰腺癌患者预后的因素,有统计学意义(P〈0.05)。而年龄、性别、血型、血糖、肿瘤部位与胰腺癌术后生存期无关,差异无统计学意义(P〉0.05);多因素分析显示术前CA19—9水平、术后病理淋巴结转移情况、临床分期是影响胰腺癌切除术后患者的独立预后因素(P〈0.05)。结论胰腺癌切除术后接受辅助治疗会使患者在生存期方面获益,但不是影响预后的独立因素;术前CA19—9水平、术后病理淋巴结转移情况、临床分期为影响胰腺癌术后患者预后的独立因素。 Objective To discuss the prognosis factors of the postoperative pancreatic cancer. Methods We collected 78 patients with pancreatic cancer resection from the Third Affiliated Hospitial of Harbin Medical University during 2005-2008 in this retrospective study, and analyzed the factors including:age, gender, glucose, blood type, symptom of pain, preoperative CA19 - 9, tumor' s position, lymph node metastasis, clinical stage,adjuvant therapy with Kaplan - Meier of univariate analysis and Cox proportional hazards model analysis of the positive factors in the multivariate analysis. Results Univariate analysis showed that preoperative CA19 -9 〉 37 U/mL,lymph node metastasis, without adjuvant therapy, clinical stage Ⅲ and with pain symptom would be bad for survival (P 〈 0.05 ). Age, gender, glucose, ABO blood type and tumor's position did not influence on sur-vival (P 〉 0.05 ). Multivariate analysis showed that preoperative CA19 -9 level, pathological lymph node metasta-sis and clinical stage were the independent prognostic factors for postoperative pancreatic cancer. Conculusion Adjuvant therapy will be benefit for the survival, but not the independent prognostic factor. Preoperative CA19 -9 level, pathological lymph node metastasis and clinical stage are independent prognostic factors for postoperative pancreatic cancer.
出处 《实用肿瘤学杂志》 CAS 2012年第6期543-547,共5页 Practical Oncology Journal
关键词 胰腺癌 预后 CA19—9 淋巴结转移 临床分期 Pancreatic cancer Prognosis CA19 - 9 Lymph node metastasis Clinical stage
  • 相关文献

参考文献16

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[ J]. CA Cancer J Olin,2005,55(2) :74 - 108.
  • 2Andren - Sandberg A, Neoptolemos JP. Resection for pan- creatic cancer in the new millennium [ J ]. Pancreatology, 2002,2(5) :431 -439.
  • 3Lira JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocareinoma:a popula- tion - based, 1 inked database analysis of 396 patients [ J ]. An Surg,2003,237( 1 ) :74 - 85.
  • 4DiMagno EP, Reber HA, Tempero MA. AGA tehrdeal reviewon the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Asso- ciation [ J ]. Gastroenterology, 1999,117 (6) : 1464 - 1484.
  • 5Muscari F, Sue B, Kimin S, et al. Risk factors for mortality and intraabdominal complication after pancreatoduodenecto- my : muhivariate analysis in 300 patients [ J ]. Surgery,2006, 139(5) :591 -598.
  • 6赵晓娇,姚玮艳,袁耀宗.胰腺癌与糖尿病的相关性研究进展[J].国际消化病杂志,2009,29(6):374-376. 被引量:3
  • 7Wolpin BM, Chan AT, Hartge PH, et al. ABO blood group and the risk of pancreatic cancer [ J ]. J Natl Cancer Inst, 2009,101(6) :424-431.
  • 8靳永春,朱桂杰,王明英.胰腺癌切除术的50例分析[J].山西医药杂志(上半月),2010,39(9):861-862. 被引量:1
  • 9肖志,石欣.影响胰腺癌病人预后的因素研究进展[J].实用肿瘤学杂志,2008,22(2):173-177. 被引量:6
  • 10Oettle H, Post S, Neuhans P, et al. Adjuvant chemotherapy with gemcitabine VS observation in patients undergoing curative - intent resection of pancreatic cancer: a random- ized controlled trim [ J ]. JAMA,2007,297 (3) :267 - 277.

二级参考文献65

  • 1匡天涛,靳大勇,楼文晖,王单松,许雪峰,倪晓凌,吴文川.胰腺癌与糖尿病关系的临床流行病学研究[J].中华消化杂志,2007,27(1):12-14. 被引量:23
  • 2Yalniz M. Pour PM. Diabetes mellitus: a risk factor for pancrea tic cancer, Langenbeck Arch Surg, 2005, 390:66-72.
  • 3Suresh T, Chari ST, Rabe KG, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology, 2008, 134:95-101.
  • 4Wang F, Gupta S, Holly EA, et al. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay area, California. Cancer Epidemiology, 2006, 15:1458-1463.
  • 5Safe S, Abdelrahim M. Sptranscription factor family and its role in cancer. Eur J Cancer, 2005, 41: 2438-2448.
  • 6Strickler HD, Wylie-Rosett J, Thomas R, et al. The relation of type 2 diabetes and cancer. Diabetes Tech Therapeut, 2001, 3: 263-274.
  • 7Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in korean men and women. JAMA, 2005, 293 : 194-202.
  • 8Stattin P, Bjor O, Ferrari P, et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care, 2007, 30: 561-567.
  • 9Zhan YS, Feng L, Tang SH, et al. Glucose metabolism disorders in cancer patients in a Chinese population[J/OL]. Med On col, [ 2009 03-05 ]. http://www. ncbi. nlm. nih. gov/ pubmed/19263254.
  • 10Bethany B, Barone S, Hsin-Chieh Yeh, et al. Long-term allcause mortality in cancer patients with preexisting diabetes mellitus a systematic review and meta-analysis. JAMA, 2008, 23: 2754-2764.

共引文献7

同被引文献16

  • 1Nicolas C Buchs,Michael Chilcott,Pierre-Alexandre Poletti,Leo H Buhler,Philippe Morel.Vascular invasion in pancreatic cancer:Imaging modalities,preoperative diagnosis and surgical management[J].World Journal of Gastroenterology,2010,16(7):818-831. 被引量:29
  • 2Ferlay J , Shin HR, Bray F , et al. Estimates of worldwide bur?den of cancer in 2008 : GLOBOCAN 2008[J] . Int J Caner, 2010,127(2) :2893 -2917.
  • 3Jemal A, Siege IR, Xu J, et a1. Cancer statistics 2010[J] . CA Cancer J Clin,2010,60(3) :277 -300.
  • 4Yang L, Parkin DM, Ferlay J , et al. Estimates of cancer inci?dence in China for 2000 and projections for 2005[J] . Canc?er Epidemiol Biomarkers Prev ,2005,14(1 ) :243 - 250.
  • 5Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin ,2011 ,61 (2) :69 - 90.
  • 6Witkowski ER, Smith JK, Tseng JF. Outcomes following re?section of pancreatic cancer[J] . J Surg Oncol, 2013 , 107 (1) :97 -103.
  • 7J emal A, Siege lR, Ward E, et a1. Cancer statistics 2009[J]. CA Cancer J Clin,2009 ,59(5) :225 -249.
  • 8Liu XE, Desmyter L, Gao CF, et al. N - Glycomic changes in hepatocellular carcinoma patients with liver cirrhosis in?duced by hepatitis B virus[J]. Hepatology, 2007 , 5 ( 5 ) : 1426 -1435.
  • 9Eskelinen M, Haglund U. Developments in serologic detec?tion of human pancreaticadenocarcinoma[J] . Scand J Gas?troenterol, 1999 ,34(9) :833 - 844.
  • 10Kokhanenko N, Ignashov AM, Varga EV, et a1. Role of the tumor markers CA19 - 9 and carcinoembryonic antigen ( CEA ) in diagnosis, treatment and prognosis of pancreatic cancer[J]. Vopr Onkol,2001 ,47 (3) :294 - 297.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部